Analyzing 10x Genomics (NASDAQ:TXG) & United Treatment Centers (OTCMKTS:POTN)

10x Genomics (NASDAQ:TXG) and United Treatment Centers (OTCMKTS:POTN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for 10x Genomics and United Treatment Centers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
10x Genomics	2	9	5	0	2.19
United Treatment Centers	0	0	0	0	0.00

10x Genomics presently has a consensus target price of $15.12, indicating a potential downside of 14.94%. Given United Treatment Centers’ higher probable upside, analysts plainly believe United Treatment Centers is more favorable than 10x Genomics.

Insider and Institutional Ownership

84.7% of 10x Genomics shares are held by institutional investors. 10.0% of 10x Genomics shares are held by insiders. Comparatively, 0.2% of United Treatment Centers shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares 10x Genomics and United Treatment Centers”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
10x Genomics	$610.78 million	3.68	-$182.63 million	($0.62)	-28.66
United Treatment Centers	N/A	N/A	N/A	N/A	N/A

United Treatment Centers has lower revenue, but higher earnings than 10x Genomics.

Profitability

This table compares 10x Genomics and United Treatment Centers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
10x Genomics	-11.89%	-11.50%	-8.93%
United Treatment Centers	N/A	N/A	N/A

Summary

10x Genomics beats United Treatment Centers on 5 of the 9 factors compared between the two stocks.

About 10x Genomics

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

About United Treatment Centers

Diamond Wellness Holdings Inc., through its subsidiaries, engages in the development and sale of hemp-derived cannabidiol (CBD) oil products. It offers flavored and unflavored oils; vaping pens and additives; edibles, such as chewable gummies and lollipops; capsules; beverage energy/relaxation shots; topical application creams in various concentrations; dog and cat wellness products in various dosages and delivery formats; skin care, bath, and body products; and hemp flowers. The company provides its products under various brands, including Diamond CBD, Chill, Relax, MediPets, and Meds BioTech, as well as various other brands. It sells its products through distributors and resellers, as well as through its Website. The company was formerly known as PotNetwork Holdings, Inc. Diamond Wellness Holdings Inc. is based in Fort Lauderdale, Florida.